Cadrenal Therapeutics (CVKD) Cash From Financing

Annual CFF

$11.90 M
NaN%

December 1, 2023


Summary


Performance

CVKD Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCVKDcash flowmetrics:

Quarterly CFF

$1.53 M
+$1.53 M+100.00%

September 1, 2024


Summary


Performance

CVKD Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCVKDcash flowmetrics:

TTM CFF

$1.52 M
-$4.98 M-76.66%

September 1, 2024


Summary


Performance

CVKD TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCVKDcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CVKD Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.0%0.0%
3 y3 years-0.0%0.0%
5 y5 years-0.0%0.0%

CVKD Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-76.5%>+9999.0%-87.3%+199.6%
5 y5-yearat highat low-76.5%>+9999.0%-87.3%+199.6%
alltimeall timeat highat low-76.5%>+9999.0%-87.3%+199.6%

Cadrenal Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.53 M(>+9900.0%)
$1.52 M(-76.7%)
Jun 2024
-
$0.00(-100.0%)
$6.50 M(0.0%)
Mar 2024
-
$300.00(-102.4%)
$6.50 M(-45.4%)
Dec 2023
$11.90 M
-$12.50 K(-100.2%)
$11.90 M(-0.1%)
DateAnnualQuarterlyTTM
Sep 2023
-
$6.51 M(>+9900.0%)
$11.92 M(+120.3%)
Jun 2023
-
$0.00(-100.0%)
$5.41 M(0.0%)
Mar 2023
-
$5.41 M(+968.9%)
$5.41 M(+968.9%)
Mar 2022
-
$506.00 K
$506.00 K

FAQ

  • What is Cadrenal Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Cadrenal Therapeutics?
  • What is Cadrenal Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Cadrenal Therapeutics?
  • What is Cadrenal Therapeutics quarterly CFF year-on-year change?
  • What is Cadrenal Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Cadrenal Therapeutics?
  • What is Cadrenal Therapeutics TTM CFF year-on-year change?

What is Cadrenal Therapeutics annual cash flow from financing activities?

The current annual CFF of CVKD is $11.90 M

What is the all time high annual CFF for Cadrenal Therapeutics?

Cadrenal Therapeutics all-time high annual cash flow from financing activities is $11.90 M

What is Cadrenal Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of CVKD is $1.53 M

What is the all time high quarterly CFF for Cadrenal Therapeutics?

Cadrenal Therapeutics all-time high quarterly cash flow from financing activities is $6.51 M

What is Cadrenal Therapeutics quarterly CFF year-on-year change?

Over the past year, CVKD quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is Cadrenal Therapeutics TTM cash flow from financing activities?

The current TTM CFF of CVKD is $1.52 M

What is the all time high TTM CFF for Cadrenal Therapeutics?

Cadrenal Therapeutics all-time high TTM cash flow from financing activities is $11.92 M

What is Cadrenal Therapeutics TTM CFF year-on-year change?

Over the past year, CVKD TTM cash flow from financing activities has changed by $0.00 (0.00%)